Parkinson's disease, genetic variability and the Faroe Islands

Maria Skaalum Petersen, Ilaria Guella, Sára Bech, Emil Gustavsson, Matthew J Farrer

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


Introduction: The Faroe Islands is a geographically isolated population in the North Atlantic with a high prevalence of Parkinson disease (PD). The disease etiology is still unknown, although dietary pollutants are considered a risk factor. The genetic risk underlying disease susceptibility has yet to be elucidated. Methods: Sequence analysis was performed in genes previously linked with PD in 91 patients and 96 healthy control subjects. Results: Fourteen missense mutations, of which one was novel, were identified in six genes. One patient (1%) did carry the known pathogenic mutation LRRK2 p.G2019S mutation, 19 patients (22%) did carry mutations of unknown significance while 70 patients (78.0%) did not have any identifiable genetic risk. A total of 14 controls (14.6%) carried mutations of unknown significance. Conclusion: This study suggests that rare variants in genes previously linked to PD are not major contributors to PD in the Faroe Islands. Further exome sequencing and comparative analyses within and among well-described pedigrees with multi-incident PD are now warranted. (C) 2014 Elsevier Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)75-78
Number of pages4
JournalParkinsonism & Related Disorders
Issue number1
Publication statusPublished - Jan 2015


  • Parkinson's disease
  • Faroe Islands
  • next-generation sequencing
  • gGenes linked to Parkinson's disease
  • prevalence
  • mutations
  • variants


Dive into the research topics of 'Parkinson's disease, genetic variability and the Faroe Islands'. Together they form a unique fingerprint.

Cite this